299 related articles for article (PubMed ID: 32631421)
1. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression.
Xia C; Liu C; He Z; Cai Y; Chen J
J Exp Clin Cancer Res; 2020 Jul; 39(1):127. PubMed ID: 32631421
[TBL] [Abstract][Full Text] [Related]
2. Vorinostat upregulates MICA via the PI3K/Akt pathway to enhance the ability of natural killer cells to kill tumor cells.
Xia C; He Z; Cai Y; Liang S
Eur J Pharmacol; 2020 May; 875():173057. PubMed ID: 32135122
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
4. Metformin induces apoptosis and inhibits migration by activating the AMPK/p53 axis and suppressing PI3K/AKT signaling in human cervical cancer cells.
Chen YH; Yang SF; Yang CK; Tsai HD; Chen TH; Chou MC; Hsiao YH
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236135
[TBL] [Abstract][Full Text] [Related]
5. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells.
Xia C; Liang S; He Z; Zhu X; Chen R; Chen J
Eur J Pharmacol; 2018 Jul; 830():59-67. PubMed ID: 29704494
[TBL] [Abstract][Full Text] [Related]
6. Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis.
Zhang Y; Li X; Zhang J; Liang H
Cancer Lett; 2020 Apr; 474():63-73. PubMed ID: 31904481
[TBL] [Abstract][Full Text] [Related]
7. HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer.
Wan PK; Leung TH; Siu MK; Mo XT; Tang HW; Chan KK; Cheung AN; Ngan HY
Cancer Lett; 2021 Jan; 497():14-27. PubMed ID: 33010383
[TBL] [Abstract][Full Text] [Related]
8. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y
Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646
[TBL] [Abstract][Full Text] [Related]
9. iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin.
Xia C; Yang F; He Z; Cai Y
Biomed Pharmacother; 2020 Mar; 123():109762. PubMed ID: 31864213
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
11. Metformin combined with nelfinavir induces SIRT3/mROS-dependent autophagy in human cervical cancer cells and xenograft in nude mice.
Xia C; He Z; Liang S; Chen R; Xu W; Yang J; Xiao G; Jiang S
Eur J Pharmacol; 2019 Apr; 848():62-69. PubMed ID: 30695683
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma.
Cheng Z; Luo C; Guo Z
J Cell Biochem; 2020 Mar; 121(3):2170-2183. PubMed ID: 31680298
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression.
Qu B; Zhao AH; Nie XZ; Sui R; Du MM; Jiang L; Wang HL
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4680-4687. PubMed ID: 31210294
[TBL] [Abstract][Full Text] [Related]
14. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway.
Chen K; Lin ZW; He SM; Wang CQ; Yang JC; Lu Y; Xie XB; Li Q
Biomed Pharmacother; 2019 Jul; 115():108875. PubMed ID: 31028998
[TBL] [Abstract][Full Text] [Related]
16. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
Wang Z; Li F; He S; Zhao L; Wang F
Gene; 2022 Jan; 809():146003. PubMed ID: 34648915
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
Yang W; Xie T
Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G
Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161
[TBL] [Abstract][Full Text] [Related]
20. Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3K/Akt pathway.
Yu X; Yang Y; Li Y; Cao Y; Tang L; Chen F; Xia J
Int J Biochem Cell Biol; 2018 Jan; 94():107-118. PubMed ID: 29175387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
